GLP-1s and the 'Forever' Question: What Happens When You Stop?

A recent article from Medscape asks a critical question on many minds: can obesity treatment with GLP-1 drugs truly last forever? This isn't just a fleeting thought; it gets to the heart of how these medications work and what you can expect from them long-term.

GLP-1 receptor agonists, like semaglutide (sold as Wegovy for weight management), are a class of medications that work by mimicking a natural hormone in your body. According to the FDA's label for Wegovy, it's indicated to reduce excess body weight and maintain weight reduction long term, in combination with a reduced-calorie diet and increased physical activity FDA Wegovy Label. They help regulate appetite and food intake, which can lead to significant weight loss.

The Challenge of Discontinuation

So, if these medications are for "long-term" use, what happens if you stop taking them? Research suggests that for many, discontinuing the medication can lead to a reversal of the weight loss achieved. A study published in Diabetes, Obesity and Metabolism in 2022, titled "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension," examined this very issue Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.. The findings from this extension of the STEP 1 trial indicated that participants who stopped semaglutide regained a significant portion of the weight they had lost within a year. This suggests that for sustained weight management, continuous treatment may be necessary.

Understanding Long-Term Use

This doesn't mean the medication isn't working; rather, it highlights that obesity is a chronic condition that often requires ongoing management. Just as medications for conditions like high blood pressure or diabetes are typically taken long-term, GLP-1s often function similarly for weight management. The goal isn't just to lose weight, but to keep it off, and for many, these medications provide the physiological support needed to do that.

Like all medications, GLP-1 drugs come with potential side effects. The FDA's label for Wegovy lists common adverse reactions, including nausea, diarrhea, vomiting, constipation, and abdominal pain FDA Wegovy Label. These are typically most pronounced when starting the medication or increasing the dose and often improve over time. Serious adverse reactions, though less common, can include acute pancreatitis and gallbladder disease. Your prescriber will discuss these risks with you.

What This Means For You

• Weight regain is common after stopping: If you discontinue GLP-1 medication, you may regain a significant portion of the weight you lost, according to studies like the STEP 1 trial extension.
• Obesity is a chronic condition: For many, successful weight management with GLP-1s may require ongoing treatment, similar to managing other chronic health conditions.
• Discuss long-term plans with your prescriber: It's important to have an open conversation about the benefits, risks, and your personal goals for long-term use with your healthcare provider.

Not medical advice. Talk to your prescriber about your situation.